Superior Hospice 511 Jenkins Street Suite B, Mansfield, LA, 71052 | |
(318) 872-2000 |
News Archive
Most children with a craniofacial deformity known as unicoronal synostosis have the eye-alignment abnormality strabismus, reports a study in the May Journal of Craniofacial Surgery , published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
A day after being sued by legally married, gay engineers, the nation's largest freight rail carriers announced they will provide health care benefits to the same-sex spouses of their employees.
Genzyme Corporation (Nasdaq: GENZ) announced today that its supplemental New Drug Application for Clolar® (clofarabine) will be discussed Tuesday, September 1 at a public meeting of the FDA's Oncologic Drugs Advisory Committee in Silver Spring, Maryland. The panel is expected to consider the clinical trial results Genzyme submitted to support the approval and labeling of Clolar to treat older adult patients with acute myeloid leukemia (AML), the most common type of acute leukemia in adults.
Researchers at the Swedish medical university Karolinska Institutet have shown for the first time that the active training of the working memory brings about visible changes in the number of dopamine receptors in the human brain.
› Verified 2 days ago
Name | Superior Hospice |
---|---|
Location | 511 Jenkins Street Suite B, Mansfield, Louisiana |
Hospice ID | 191664 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Other |
Profit Type | FOR PROFIT |
Accreditation Provider | The Joint Commission (TJC) |
SSA county code | 150 |
News Archive
Most children with a craniofacial deformity known as unicoronal synostosis have the eye-alignment abnormality strabismus, reports a study in the May Journal of Craniofacial Surgery , published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
A day after being sued by legally married, gay engineers, the nation's largest freight rail carriers announced they will provide health care benefits to the same-sex spouses of their employees.
Genzyme Corporation (Nasdaq: GENZ) announced today that its supplemental New Drug Application for Clolar® (clofarabine) will be discussed Tuesday, September 1 at a public meeting of the FDA's Oncologic Drugs Advisory Committee in Silver Spring, Maryland. The panel is expected to consider the clinical trial results Genzyme submitted to support the approval and labeling of Clolar to treat older adult patients with acute myeloid leukemia (AML), the most common type of acute leukemia in adults.
Researchers at the Swedish medical university Karolinska Institutet have shown for the first time that the active training of the working memory brings about visible changes in the number of dopamine receptors in the human brain.
› Verified 2 days ago
NPI Number | 1255521183 |
Organization Name | Superior Hospice Of Northwest Louisiana, Llc |
Address | 511 Jenkins St. Mansfield, Louisiana, 71052 |
Phone Number | (318)872-2000 |
News Archive
Most children with a craniofacial deformity known as unicoronal synostosis have the eye-alignment abnormality strabismus, reports a study in the May Journal of Craniofacial Surgery , published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
A day after being sued by legally married, gay engineers, the nation's largest freight rail carriers announced they will provide health care benefits to the same-sex spouses of their employees.
Genzyme Corporation (Nasdaq: GENZ) announced today that its supplemental New Drug Application for Clolar® (clofarabine) will be discussed Tuesday, September 1 at a public meeting of the FDA's Oncologic Drugs Advisory Committee in Silver Spring, Maryland. The panel is expected to consider the clinical trial results Genzyme submitted to support the approval and labeling of Clolar to treat older adult patients with acute myeloid leukemia (AML), the most common type of acute leukemia in adults.
Researchers at the Swedish medical university Karolinska Institutet have shown for the first time that the active training of the working memory brings about visible changes in the number of dopamine receptors in the human brain.
› Verified 2 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 100.0 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 94.6 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 46.2 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 99.1 | 97.3 |
Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 98.2 | 93.3 |
News Archive
Most children with a craniofacial deformity known as unicoronal synostosis have the eye-alignment abnormality strabismus, reports a study in the May Journal of Craniofacial Surgery , published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
A day after being sued by legally married, gay engineers, the nation's largest freight rail carriers announced they will provide health care benefits to the same-sex spouses of their employees.
Genzyme Corporation (Nasdaq: GENZ) announced today that its supplemental New Drug Application for Clolar® (clofarabine) will be discussed Tuesday, September 1 at a public meeting of the FDA's Oncologic Drugs Advisory Committee in Silver Spring, Maryland. The panel is expected to consider the clinical trial results Genzyme submitted to support the approval and labeling of Clolar to treat older adult patients with acute myeloid leukemia (AML), the most common type of acute leukemia in adults.
Researchers at the Swedish medical university Karolinska Institutet have shown for the first time that the active training of the working memory brings about visible changes in the number of dopamine receptors in the human brain.
› Verified 2 days ago
Home Health Aides | 5 |
Counselors | 1 |
Homemakers | 1 |
Licensed Practical or Vocational Nurses | 1 |
Medical Social Workers | 1 |
Physicians | 0.25 |
Registered Nurses | 4 |
Total Employees | 13.25 |
---|
News Archive
Most children with a craniofacial deformity known as unicoronal synostosis have the eye-alignment abnormality strabismus, reports a study in the May Journal of Craniofacial Surgery , published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
A day after being sued by legally married, gay engineers, the nation's largest freight rail carriers announced they will provide health care benefits to the same-sex spouses of their employees.
Genzyme Corporation (Nasdaq: GENZ) announced today that its supplemental New Drug Application for Clolar® (clofarabine) will be discussed Tuesday, September 1 at a public meeting of the FDA's Oncologic Drugs Advisory Committee in Silver Spring, Maryland. The panel is expected to consider the clinical trial results Genzyme submitted to support the approval and labeling of Clolar to treat older adult patients with acute myeloid leukemia (AML), the most common type of acute leukemia in adults.
Researchers at the Swedish medical university Karolinska Institutet have shown for the first time that the active training of the working memory brings about visible changes in the number of dopamine receptors in the human brain.
› Verified 2 days ago
Others | 2 |
Total Volunteers | 2 |
---|
News Archive
Most children with a craniofacial deformity known as unicoronal synostosis have the eye-alignment abnormality strabismus, reports a study in the May Journal of Craniofacial Surgery , published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
A day after being sued by legally married, gay engineers, the nation's largest freight rail carriers announced they will provide health care benefits to the same-sex spouses of their employees.
Genzyme Corporation (Nasdaq: GENZ) announced today that its supplemental New Drug Application for Clolar® (clofarabine) will be discussed Tuesday, September 1 at a public meeting of the FDA's Oncologic Drugs Advisory Committee in Silver Spring, Maryland. The panel is expected to consider the clinical trial results Genzyme submitted to support the approval and labeling of Clolar to treat older adult patients with acute myeloid leukemia (AML), the most common type of acute leukemia in adults.
Researchers at the Swedish medical university Karolinska Institutet have shown for the first time that the active training of the working memory brings about visible changes in the number of dopamine receptors in the human brain.
› Verified 2 days ago
Superior Hospice Location: 511 Jenkins Street Suite B, Mansfield, Louisiana, 71052 Phone: (318) 872-2000 |